Loading provider…
Loading provider…
Allergy Physician in Baltimore, MD
NPI: 1225085301HQ Phone
Get M.D. Peter's Phone Numberphone_androidMobile
Get M.D. Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
A 300 IR sublingual tablet is an effective, safe treatment for house dust mite-induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial.
Authors: Thomas Casale, Jonathan Corren
Publication Date: 2019-12-30
Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses.
Authors: Stephen Durham, Peter Creticos, Harold Nelson, Ziliang Li, Amarjot Kaur, Eli Meltzer, Hendrik Nolte
Publication Date: 2016-01-25
Lead Sponsor: Abionic SA
Collaborators: Johns Hopkins University, NAMSA
Intervention / Treatment: DEVICE: Blood Collection
Lead Sponsor: Johns Hopkins University
Collaborators: Schering-Plough
Intervention / Treatment: DRUG: Mometasone, DRUG: Advair
Lead Sponsor: Johns Hopkins University
Collaborators: Genentech, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: omalizumab